StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.44+0.06 (+15.11%)

Close on Nov 18, 2026Market cap $56.14MP/E –Yield –

Oncolytics Biotech r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2024 it was C$21.65M, up 22.2% from the year before. The highest annual figure on record is C$21.65M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024Dec 31, 2024C$21.65M+22.2%
FY2023Dec 31, 2023C$17.71M+14.8%
FY2022Dec 31, 2022C$15.43M+19.4%
FY2021Dec 31, 2021C$12.92M-0.2%
FY2020Dec 31, 2020C$12.95M+19.7%
FY2019Dec 31, 2019C$10.82M+7.9%
FY2018Dec 31, 2018C$10.03M+6.8%
FY2017Dec 31, 2017C$9.39M-3.9%
FY2016Dec 31, 2016C$9.77M+13.6%
FY2015Dec 31, 2015C$8.60M–

More Oncolytics Biotech figures

See a number that looks wrong?